Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-15 | Cidara Therapeutics, Inc. | Ward Shane
(COO & CLO) |
A | Common Stock | A | 120000 | $0.00 - $0.00 | $0 |
| 2024-03-15 | Cidara Therapeutics, Inc. | Shah Preetam
(CFO & CBO) |
A | Common Stock | A | 108750 | $0.00 - $0.00 | $0 |
| 2024-03-15 | Cidara Therapeutics, Inc. | Tari Leslie
(CHIEF SCIENTIFIC OFFICER) |
A | Common Stock | A | 111250 | $0.00 - $0.00 | $0 |
| 2024-03-15 | Cidara Therapeutics, Inc. | Sandison Taylor
(Chief Medical Officer) |
A | Common Stock | A | 128750 | $0.00 - $0.00 | $0 |
| 2024-03-11 | Cidara Therapeutics, Inc. | Stein Jeffrey
(President & CEO) |
F | Common Stock | D | 56692 | $0.69 - $0.69 | $39,117 |
| 2024-03-11 | Cidara Therapeutics, Inc. | Tari Leslie
(CHIEF SCIENTIFIC OFFICER) |
S | Common Stock | D | 21029 | $0.67 - $0.67 | $14,085 |
| 2024-03-11 | Cidara Therapeutics, Inc. | Sandison Taylor
(Chief Medical Officer) |
S | Common Stock | D | 20662 | $0.67 - $0.67 | $13,839 |
| 2024-03-11 | Cidara Therapeutics, Inc. | Ward Shane
(COO & CLO) |
S | Common Stock | D | 20473 | $0.67 - $0.67 | $13,712 |
| 2024-03-11 | Cidara Therapeutics, Inc. | Shah Preetam
(CFO & CBO) |
S | Common Stock | D | 18931 | $0.67 - $0.67 | $12,679 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |